Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
09/2005
09/21/2005EP1575548A2 Compositions and methods for promoting neuronal outgrowth
09/21/2005EP1575531A2 THERAPIES FOR CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY USING INTERFERON-&bgr;
09/21/2005EP1575528A2 Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
09/21/2005EP1575524A2 Proliferated cell lines and uses thereof
09/21/2005EP1575521A2 Pharmaceutical composition of 1-(3-hydroxy-4-methoxyphenyl)-4-methyl-5-ethyl-7,8-dimethoxy-5h-2,3-benzodiazepine and uses therof
09/21/2005EP1575517A2 Anti-ngf antibodies and methods using same
09/21/2005EP1575510A2 Compositions and methods for the treatment of diseases exhibiting protein misassembly and aggregation
09/21/2005EP1575499A2 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses
09/21/2005EP1575480A2 Compositions and methods for the treatment of immune related diseases
09/21/2005EP1461037A4 Beverage treated with nicotine
09/21/2005EP1420790B1 Use of bibn4096 in combination with other antimigraine drugs for the treatment of migraine
09/21/2005EP1377560B1 Piperazine derivatives as tachykinin antagonists
09/21/2005EP1339694B1 Substituted 2-phenylaminoimidazoline phenyl ketone derivatives as ip antagonists
09/21/2005EP1303501B1 Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging
09/21/2005EP1265862B1 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
09/21/2005EP1140091B1 Formulations comprising imiquimod or other immune response modifiers for treating cervical dysplasia
09/21/2005EP1129188B1 Pge synthase and methods and means for modulating its activity
09/21/2005EP1094830B1 USE OF COMPOSITION COMPRISING AT LEAST ONE SUBSTANCE WITHIN THE GROUP GnRH-ANALOGUES FOR TREATMENT OF OBSESSIVE-COMPULSIVE DISORDER (OCD)
09/21/2005EP1061805B1 Regulation of endogenous gene expression in cells using zinc finger proteins
09/21/2005EP0994710B2 Pharmaceutical compositions for oral administration, comprising a benzhydrylpiperazine and a cyclodextrin
09/21/2005EP0846171B1 Chromosome 1 gene and gene products related to alzheimer's disease
09/21/2005CN1671844A Antigenic neisserial peptides
09/21/2005CN1671835A A method for the establishment of a pluripotent human blastocyst-derived stem cell line
09/21/2005CN1671730A Oligonucleotide-containing pharmacological compositions and their use
09/21/2005CN1671715A Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors
09/21/2005CN1671714A Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use
09/21/2005CN1671711A Calcitonin gene related peptide receptor antagonists
09/21/2005CN1671701A Novel aryllimidazole derivatives, preparation and therapeutic used thereof
09/21/2005CN1671694A Bisindolyl-maleimid derivatives as kinase inhibitors
09/21/2005CN1671680A Compound for treatment of anxiety and methods of preparation and use thereof
09/21/2005CN1671671A 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) im
09/21/2005CN1671668A 4-(substituted aryl)-5-hydroxyisoquinolinone derivative
09/21/2005CN1671666A Vegfr-2 and vegfr-3 inhibitory anthranylamidopyridines
09/21/2005CN1671662A Piperidine derivative, process for producing the same, and use
09/21/2005CN1671650A Crystalline beta2 adrenergic receptor agonist
09/21/2005CN1671643A Bipolar trans carotenoid salts and their uses
09/21/2005CN1671639A Novel biphenyl and biphenyl-like cannabinoids
09/21/2005CN1671421A Inclusion complexes of rosiglitazone
09/21/2005CN1671417A Anti-myelin associated glycoprotein (MAG) antibodies
09/21/2005CN1671391A Novel methods and compositions for alleviating pain
09/21/2005CN1671390A Adenosine A2A receptor antagonists for treating restless legs syndrome or related disorders
09/21/2005CN1671388A Sustained-release tablet composition comprising a dopamine receptor agonist
09/21/2005CN1671387A Aryl substituted hydantoin compounds and their use as sodium channel blockers
09/21/2005CN1671386A Substituted anilinic piperidines as MCH selective antagonists
09/21/2005CN1671383A Sustained-release tablet comprising reboxetine
09/21/2005CN1671382A Sustained-release tablet composition of pramipexole
09/21/2005CN1671381A Pramipexole once-daily dosage form
09/21/2005CN1671377A 1H-1, 2, 4-triazole-3-carboxamide derivatives as cannabinoid-CB receptor ligands
09/21/2005CN1671375A Improved transdermal delivery system for the administration of rotigotine
09/21/2005CN1671365A Improved transdermal delivery system
09/21/2005CN1671363A Extended release formulation of divalproex sodium
09/21/2005CN1671358A Dosage forms and compositions for osmotic delivery of variable dosages of oxycodone
09/21/2005CN1669570A Medicinal composition for treating senile dementia and vascular dementia and preparing process thereof
09/21/2005CN1669552A Ethylamine thiourea injection and preparation method thereof
09/21/2005CN1219868C Wine containing sobering-up factor
09/21/2005CN1219795C Renaturation process for preparing human recombinant nerve growth factor
09/21/2005CN1219776C Thiophene substituted amine derivatives as GLYT-1 inhibitors
09/21/2005CN1219763C Substituted indole mannich bases
09/21/2005CN1219753C Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
09/21/2005CN1219748C Solid compositions suitable for oral administration containing non-hydroscopic salts of L-carnitine and alkanoyl L-carnitines with taurine chloride and glycine chloride
09/21/2005CN1219528C Proprietary Chinese traditional medicine for treating drug dependence
09/21/2005CN1219513C Application of amyl ethyl quin ether hydrochloride
09/21/2005CN1219509C Use of rosmarinic acid and derivatives thereof as immunosuppressant or inhibitor of SHz-mediated process
09/20/2005US6946579 3-carbocycle carbonyl-3-phenylpropionaldehyde intermediates and preparation by alkylating a carbocycle benzyl ketone with an allyl halide and oxidizing the product
09/20/2005US6946558 Bipyridinyl derivatives as a highly selective cyclooxygenase-2 inhibitor
09/20/2005US6946548 Granulocyte colony stimulating factor ("G-CSF") analog polypeptide compositions, related nucleic acids, expression constructs, host cells, and processes for recombinant production of the present G-CSF analogs.
09/20/2005US6946491 such as 3-[(4-(2-fluorobenzyloxy)phenyl)-methylthio]propionic acid; for treatment of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis
09/20/2005US6946487 Regulation of intracellular glucocorticoid concentrations
09/20/2005US6946474 Nitrogen-containing compounds and their use as glycine transport inhibitors
09/20/2005US6946468 that inhibit farnesylation of mutant ras gene products; cancer; (2)-2-(2-methoxy-ethyl)-1-((cis)-3-sulfanyl-pyrrolidin-2-ylmethyl)-4-naphthoyl-piperazine
09/20/2005US6946466 Aromatic sulfonamides as peroxynitrite-rearrangement catalysts
09/20/2005US6946464 Methods of treating and preventing a convulsive state
09/20/2005US6946463 1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-diones and their use for the treatment of pain
09/20/2005US6946461 Cognition activators
09/20/2005US6946459 Crystalline forms of 1s-[1alpha(2s*,3r*), 9alpha]6, 10-dioxo-n-(2-ethoxy-5-oxo-tetrahydro-3-furanyl)-9[[(1-isoquinolyl) carbonyl]amino]octahydro-6h-piridazino[1,2-a][1,2]diazepin-1-carboxamide
09/20/2005US6946445 peptide antagonists of CXC chemokine receptor 4, CXCR4; cancer and autoimmune diseases; protein that comprises an N-terminal sequence of KGVSLSYR (SEQ ID NO: 3); stromal cell derived factor one (SDF-1 ligand
09/20/2005US6946244 Detecting the activity of orphan G Protein Receptor 86 by incubating a sample comprising GPR86 and adenosine diphosphate (ADP) under binding conditions for both and detecting a second messanger; screening for a modulator
09/20/2005US6946135 Prevention and treatment of amyloidogenic disease
09/20/2005US6946129 Recombinant anti-CD40 antibody and uses thereof
09/20/2005US6946116 Amyloid plaque aggregation inhibitors and diagnostic imaging agents
09/20/2005CA2348869C Pharmaceutical preparations for external use containing non-steroidal anti-inflammatory and analgesic agents
09/20/2005CA2274946C Diphenylalkyl-tetrahydropyridines, process for their preparation, and pharmaceutical compositions containing them
09/20/2005CA2231535C Imidazole derivatives having affinity for alpha2 receptors activity
09/20/2005CA2211668C Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing the same
09/20/2005CA2151604C Application of riluzole in the treatment of neurological lesions associated with traumas
09/20/2005CA2113515C Inhibiting the development of tolerance to and/or dependence on an addictive substance
09/19/2005CA2465600A1 Dosage titration for treatment of cognitive disorders
09/15/2005WO2005085267A1 Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs
09/15/2005WO2005085228A1 Cycloalkanopyridine derivative
09/15/2005WO2005085214A1 Diaryl-substituted five-membered heterocycle derivative
09/15/2005WO2005085212A1 Substituted pyrimidine derivative
09/15/2005WO2005085210A1 Nitriles and medicinal compositions containing the same as the active ingredient
09/15/2005WO2005085200A1 Pyridone derivative
09/15/2005WO2005085195A1 Medicinal composition for prevention or treatment of overactive bladder accompanying nervous disorder
09/15/2005WO2005084707A1 Method of utilizing organic cation transporter oct3-related molecule for treating mental diseases such as depression, anxiety neurosis, drug addiction and the like
09/15/2005WO2005084679A1 Composition containing benzamidine derivative and method for stabilizing benzamidine derivative
09/15/2005WO2005084665A1 Niosome having metal porphyrin complex embedded therein, process for producing the same and drug with the use thereof
09/15/2005WO2004029019A8 Compounds for the treatment of alzheimer’s disease
09/15/2005WO2003000844A3 Protein modification and maintenance molecules
09/15/2005US20050203296 Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders
1 ... 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 ... 1833